Childhood Vaccines Completely Alter the Genes of Children According to Massive Study

"67 cancer-related genes activated instantly..."

In a presentation that zeroes in on the microscopic aftermath of early childhood vaccination, Dr. Suzanne Humphries points to a 2008 Swedish study she says raises questions about how infant immune systems respond on a genetic level.

The study examined babies who received a routine series of vaccines at three and five months of age—shots that included diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b.

According to Humphries, researchers then drew blood from the infants and exposed the samples to pertussis toxin, a component associated with the whooping cough vaccine.

What happened next, she says, was measured not in symptoms or visible illness, but in gene expression. Twelve hours after exposure, the study reportedly found that dozens of genes linked to various conditions had been “activated” or “upregulated.”

Humphries cites specific figures: 33 allergy-related genes switched on, 66 genes connected to asthma activated, 67 cancer-related genes upregulated, and 25 genes tied to immune function also showing increased activity.

The language she uses frames this as a kind of genetic awakening—cells responding at a deep biological level to the substances they encountered.

Her retelling emphasizes that these changes occurred in a laboratory setting, in blood samples taken from vaccinated infants and then exposed to pertussis toxin outside the body.

She underscores that the study did not claim immediate disease development in the children involved.

Instead, she presents the findings as evidence of genetic “waking up,” a process that may or may not translate into real-world health outcomes.

The question she poses is not whether every child becomes ill, but what happens if such genetic activations are not later “shut down,” and whether long-term consequences could emerge.

Humphries frames the study as a glimpse into the hidden molecular choreography of the immune system.

She describes a cascade of activity that unfolds hours after exposure—genes flickering on, signaling pathways stirring, and the body’s defensive machinery shifting into motion.

The numbers she recites—33, 66, 67, 25—are delivered like markers in a ledger, a tally of responses occurring beneath the surface of ordinary clinical observation.

Her account suggests definitive causation between these genetic changes and specific diseases. She presents the study as an open-ended signal, a snapshot of biological activity that invites further investigation.

The central theme of her discussion is uncertainty: the idea that gene activation may represent a temporary adjustment, or something more enduring, depending on what follows. She asks what happens if nothing intervenes to reverse these activations, and whether the long-term trajectory of those genes is fully understood.

In Humphries’ telling, the 2008 Swedish study becomes a focal point in a broader conversation about how medical interventions interact with the genome. It is portrayed as a moment when the veil lifts on processes usually hidden from view—immune systems reacting, genes responding, and scientists peering into the aftermath.

Whether the implications are fleeting or profound, she suggests, remains a question still echoing in the wake of those laboratory findings.

Humphries closes her discussion by placing the Swedish findings alongside a wider body of research that has examined how vaccines and immune challenges can influence gene expression in the short term.

She references work from systems-biology studies that track how immune cells respond at a molecular level after vaccination, including research showing temporary shifts in inflammatory and immune-regulating genes in the hours and days following exposure.

Some studies using transcriptomic analysis—large-scale examinations of RNA activity—have documented rapid but often transient changes in immune pathways after routine childhood immunizations, with researchers describing these shifts as part of the body’s normal defensive signaling process.

Several papers in the field of immunogenomics have reported that gene activation patterns can vary widely depending on dose, timing, and the individual biology of the person involved. Longitudinal studies have also examined how these molecular changes settle over time, with some tracking whether gene expression returns to baseline levels after the initial immune response subsides.